by definition of VAs, process/system has to add to product feature/functionality,.
From pharma perspective, being a critical operation, there are more unit operations relying on inspection, quality control. and some instances, inspection is mandated by regulations and standards.
so, should the inspection be really categorized as NVA?
From pharma perspective, being a critical operation, there are more unit operations relying on inspection, quality control. and some instances, inspection is mandated by regulations and standards.
so, should the inspection be really categorized as NVA?
Inspection takes many forms in pharma: visual analysis, record review, audits, and walkarounds, and yet Six Sigma
regards inspection as fundamentally unproductive and “non-value added.” In addition to the fact a process should be
improved to make inspection less prevalent, it is clear that the cost and time required to inspect and fix problems is beyond
what most customers would pay, if given the choice.